Baek Hae Woon, Park Min Jee, Rhee Ye-Young, Lee Kyoung Bun, Kim Min A, Park In Ae
Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
J Pathol Transl Med. 2015 Jan;49(1):52-60. doi: 10.4132/jptm.2014.10.26. Epub 2015 Jan 15.
Endoscopic ultrasound-guided fine needle aspiration cytology (EUS-FNAC) is currently the most commonly used procedure for obtaining cytologic specimens of the pancreas. It is accurate, minimally invasive, safe and cost-effective. However, there is discrepancy between cytological and surgical diagnoses. This study was aimed at evaluating the diagnostic accuracy of EUS-FNAC of the pancreas.
We performed a retrospective review of 191 cases of pancreatic lesions initially diagnosed by EUS-FNAC with subsequent histological diagnosis between 2010 and 2012 in the Department of Pathology, Seoul National University Hospital. Cytologic and surgical diagnoses were categorized into five groups: negative, benign, atypical, malignant, and insufficient for diagnosis. Subsequently, 167 cases with satisfactory yield in both surgical and cytology specimens were statistically analyzed to determine correlations with diagnosis.
In comparison to surgical diagnoses, cytologic diagnoses were true-positive in 103 cases (61.7%), true-negative in 28 cases (16.8%), false-positive in 9 cases (5.4%), and false-negative in 27 cases (16.1%). The diagnostic accuracy was 78.4%, sensitivity was 79.2%, and specificity was 75.7%. The positive predictive value was 92.0%, and negative predictive value was 50.9%.
EUS-FNAC has high accuracy, sensitivity, specificity and positive predictive value. Overcoming the limitations of EUS-FNAC will make it a useful and reliable diagnostic tool for accurate evaluation of pancreatic lesions.
内镜超声引导下细针穿刺细胞学检查(EUS-FNAC)是目前获取胰腺细胞学标本最常用的方法。它准确、微创、安全且具有成本效益。然而,细胞学诊断与手术诊断之间存在差异。本研究旨在评估EUS-FNAC对胰腺疾病的诊断准确性。
我们对2010年至2012年期间首尔国立大学医院病理科最初经EUS-FNAC诊断并随后进行组织学诊断的191例胰腺病变病例进行了回顾性研究。细胞学和手术诊断分为五组:阴性、良性、非典型、恶性和诊断不足。随后,对手术和细胞学标本取材均满意的167例病例进行统计学分析,以确定与诊断的相关性。
与手术诊断相比,细胞学诊断真阳性103例(61.7%),真阴性28例(16.8%),假阳性9例(5.4%),假阴性27例(16.1%)。诊断准确率为78.4%,敏感性为79.2%,特异性为75.7%。阳性预测值为92.0%,阴性预测值为50.9%。
EUS-FNAC具有较高的准确性、敏感性、特异性和阳性预测值。克服EUS-FNAC的局限性将使其成为准确评估胰腺病变的有用且可靠的诊断工具。